NCT00985491

Study for Short Term Weight Loss in Candidates for Bariatric Surgery

A Pilot Trial of the GI EndoBarrier Liner for Short Term Weight Loss in Subjects Who Are Candidates for Bariatric Surgery

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 46 (actual)
• Sponsor: Morphic Medical Inc. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the GI Endobarrier Liner is safe and effective.

Detailed description

Patients with obesity are at significantly greater risk of developing significant co-morbid complications, and are associated with an increased risk in all-cause mortality. The GI Endobarrier Liner represents a viable alternative to other short-term weight loss methods. It is a minimally invasive endoscopic procedure, which may allow patients to recover faster with less morbidity and mortality. This study is investigating the safety and efficacy of the GI Endobarrier Liner in patients who are candidates for bariatric surgery.

Conditions

• Obesity

Interventions

Type	Name	Description
DEVICE	Endobarrier Liner	Medical device placed endoscopically in the duodenum

Timeline

• Start date: 2008-10-01
• Primary completion: 2015-07-01
• Completion: 2015-07-01
• First posted: 2009-09-28
• Last updated: 2016-09-15
• Results posted: 2016-08-03

Locations

1 site across 1 country: Chile